Cognito Therapeutics
Cognito Therapeutics is dedicated to developing innovative therapeutics to improve the lives of patients with neurodegenerative diseases, particularly Alzheimer's disease. Their approach involves evoking specific brain wave activity through non-invasive sensory stimulation, aiming to preserve brain structure, cognition, and function. The company is advancing a novel category of disease-modifying therapy, supported by groundbreaking research from MIT, and has received FDA Breakthrough Device Designation for their treatment. They focus on slowing disease progression, enhancing patient quality of life, and expanding their approach to other neurodegenerative conditions.
Industries
Nr. of Employees
small (1-50)
Cognito Therapeutics
Products
Wearable visual-auditory stimulation headset for daily home therapy
A wearable device designed to deliver coordinated visual and auditory stimulation for one-hour daily treatment sessions in a home setting, with individualized intensity settings guided by EEG tolerability and response.
Wearable visual-auditory stimulation headset for daily home therapy
A wearable device designed to deliver coordinated visual and auditory stimulation for one-hour daily treatment sessions in a home setting, with individualized intensity settings guided by EEG tolerability and response.
Services
Randomized clinical trial design and execution for non-invasive neuromodulation
Design and operational execution of randomized, sham-controlled, double-blind multicenter trials including endpoint selection, site management, safety monitoring, and open-label extensions.
Randomized clinical trial design and execution for non-invasive neuromodulation
Design and operational execution of randomized, sham-controlled, double-blind multicenter trials including endpoint selection, site management, safety monitoring, and open-label extensions.
Expertise Areas
- Neuromodulation for neurodegenerative disease
- Clinical trial management (randomized, sham-controlled, double-blind)
- Home-based medical device therapy deployment
- Biomarker development and verification (EEG, MRI)
Key Technologies
- Electroencephalography (EEG)
- Non-invasive visual and auditory sensory stimulation
- Wearable headset hardware for therapeutic delivery
- Structural MRI volumetric analysis